Biomarker predicts bowel cancer recurrence

A biomarker in the blood of patients with bowel cancer may provide valuable insight into the risk of cancer relapse after surgery and the effectiveness of chemotherapy.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *